DorisGay YeeLeungMDPhD

Neurology • Baltimore, MD

Neuromuscular Medicine, Neurophysiology

Associate Professor of Neurology, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Leung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leung's full profile

Already have an account?

Office
716 N. Broadway
Suite 411
Baltimore, MD 21205
Phone+1 410-550-5624

Fax+1 443-923-9545

Education & Training

Johns Hopkins Bloomberg School of Public HealthPhD, Clinical Investigation, 2013 - 2016
Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2010 - 2014
Stanford Health Care-Sponsored Stanford UniversityFellowship, Clinical Neurophysiology, 2009 - 2010
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 2006 - 2009
Duke University HospitalInternship, Internal Medicine, 2005 - 2006
Duke University School of MedicineClass of 2005
Harvard UniversityBA, Biochemical Sciences, Magna cum laude, 1997 - 2001

Certifications & Licensure

MD State Medical License 2010 - 2026
CA State Medical License 2007 - 2010
NC State Medical License 2005 - 2006
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology

Clinical Trials

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy Start of enrollment: 2012 Mar 01
Active, not recruiting
Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy Start of enrollment: 2014 Nov 01
Completed
Phase 2
A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy Start of enrollment: 2014 Nov 24
Terminated
Phase 2
A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1 Start of enrollment: 2014 Dec 01
Completed
Phase 1, Phase 2
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy Start of enrollment: 2015 Jun 30
Completed
Phase 2
Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD Start of enrollment: 2015 Dec 02
Terminated
Phase 1, Phase 2
Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients Start of enrollment: 2015 Oct 08
Completed
Phase 1
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) Start of enrollment: 2015 Nov 30
Completed
Phase 1, Phase 2
A Trial of PF-06252616 in Ambulatory Participants With LGMD2I Start of enrollment: 2016 Jul 01
Completed
Phase 1, Phase 2
Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) Start of enrollment: 2023 May 31
Recruiting
Phase 3
Roles: Contact, Principal Investigator
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1) Start of enrollment: 2023 Mar 12
Recruiting
Phase 1, Phase 2
Defining Endpoints in Becker Muscular Dystrophy Start of enrollment: 2022 Apr 13
Recruiting
Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) Start of enrollment: 2019 Jun 14
Recruiting
Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Start of enrollment: 2020 Oct 19
Recruiting
Phase 2
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) Start of enrollment: 2020 Dec 15
Recruiting
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD Start of enrollment: 2018 Mar 05
Active, not recruiting
Biomarker Development in LGMD2i Start of enrollment: 2019 Dec 01
Completed
Join now to see all

Publications & Presentations

PubMed

Prospective observational study of FKRP-related limb-girdle muscular dystrophy R9: A GRASP consortium study.
Lindsay N Alfano, Meredith K James, Kristine Grosfjeld Petersen, Karen Rudolf, John Vissing
Annals of Clinical and Translational Neurology. 2024-12-15
3 citations
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Rabi Tawil, Kathryn R Wagner, Johanna I Hamel, Doris G Leung, Jeffrey M Statland
The Lancet. Neurology. 2024-05-01
1 citations
Education Research: Evaluating Medical Student Learning Preference and Its Relationship to Clerkship Satisfaction.
Margo A Peyton, Andrew S Lea, Roy E Strowd 3rd, Rachel Marie E Salas, Charlene E Gamaldo
Neurology. Education. 2023-12-22

Professional Memberships

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/doris-leung
Kennedy Krieger Institutehttps://www.kennedykrieger.org/patient-care/faculty-staff/doris-leung